Targeted NGS Platforms for Genetic Screening and Gene Discovery in Primary Immunodeficiencies

Background: Primary Immunodeficiencies (PIDs) are a heterogeneous group of genetic immune disorders. While some PIDs can manifest with more than one phenotype, signs, and symptoms of various PIDs overlap considerably. Recently, novel defects in immune-related genes and additional variants in previously reported genes responsible for PIDs have been successfully identified by Next Generation Sequencing (NGS), allowing the recognition of a broad spectrum of disorders. Objective: To evaluate the strength and weakness of targeted NGS sequencing using custom-made Ion Torrent and Haloplex (Agilent) panels for diagnostics and research purposes. Methods: Five different panels including known and candidate genes were used to screen 105 patients with distinct PID features divided in three main PID categories: T cell defects, Humoral defects and Other PIDs. The Ion Torrent sequencing platform was used in 73 patients. Among these, 18 selected patients without a molecular diagnosis and 32 additional patients were analyzed by Haloplex enrichment technology. Results: The complementary use of the two custom-made targeted sequencing approaches allowed the identification of causative variants in 28.6% (n = 30) of patients. Twenty-two out of 73 (34.6%) patients were diagnosed by Ion Torrent. In this group 20 were included in the SCID/CID category. Eight out of 50 (16%) patients were diagnosed by Haloplex workflow. Ion Torrent method was highly successful for those cases with well-defined phenotypes for immunological and clinical presentation. The Haloplex approach was able to diagnose 4 SCID/CID patients and 4 additional patients with complex and extended phenotypes, embracing all three PID categories in which this approach was more efficient. Both technologies showed good gene coverage. Conclusions: NGS technology represents a powerful approach in the complex field of rare disorders but its different application should be weighted. A relatively small NGS target panel can be successfully applied for a robust diagnostic suspicion, while when the spectrum of clinical phenotypes overlaps more than one PID an in-depth NGS analysis is required, including also whole exome/genome sequencing to identify the causative gene.

[1]  P. Palma,et al.  Next-Generation Sequencing Reveals A JAGN1 Mutation in a Syndromic Child With Intermittent Neutropenia , 2019, Journal of pediatric hematology/oncology.

[2]  C. Cancrini,et al.  First Case of Patient With Two Homozygous Mutations in MYD88 and CARD9 Genes Presenting With Pyogenic Bacterial Infections, Elevated IgE, and Persistent EBV Viremia , 2019, Front. Immunol..

[3]  M. Degano,et al.  ALPS-Like Phenotype Caused by ADA2 Deficiency Rescued by Allogeneic Hematopoietic Stem Cell Transplantation , 2019, Front. Immunol..

[4]  J. Casanova,et al.  T-cell defects in patients with ARPC1B germline mutations account for combined immunodeficiency. , 2018, Blood.

[5]  J. Flowers,et al.  Origins and geographic diversification of African rice (Oryza glaberrima) , 2018, bioRxiv.

[6]  C. Cancrini,et al.  JAK3 mutations in Italian patients affected by SCID: New molecular aspects of a long‐known gene , 2018, Molecular genetics & genomic medicine.

[7]  M. Yılmaz,et al.  The Utility of Next-Generation Sequencing for Primary Immunodeficiency Disorders: Experience from a Clinical Diagnostic Laboratory , 2018, BioMed research international.

[8]  J. Orange,et al.  Use of Genetic Testing for Primary Immunodeficiency Patients , 2018, Journal of Clinical Immunology.

[9]  C. Cancrini,et al.  Theophylline as a precision therapy in a young girl with PIK3R1 immunodeficiency. , 2018, The journal of allergy and clinical immunology. In practice.

[10]  C. Mattocks,et al.  Clinical efficacy of a next‐generation sequencing gene panel for primary immunodeficiency diagnostics , 2018, Clinical genetics.

[11]  E. Lanino,et al.  CD70 Deficiency due to a Novel Mutation in a Patient with Severe Chronic EBV Infection Presenting As a Periodic Fever , 2018, Front. Immunol..

[12]  C. Cancrini,et al.  Novel X-Linked Inhibitor of Apoptosis Mutation in Very Early-Onset Inflammatory Bowel Disease Child Successfully Treated with HLA-Haploidentical Hemapoietic Stem Cells Transplant after Removal of αβ+ T and B Cells , 2017, Front. Immunol..

[13]  I. Barshack,et al.  Disruption of Thrombocyte and T Lymphocyte Development by a Mutation in ARPC1B , 2017, The Journal of Immunology.

[14]  Steven M. Holland,et al.  International Union of Immunological Societies: 2017 Primary Immunodeficiency Diseases Committee Report on Inborn Errors of Immunity , 2017, Journal of Clinical Immunology.

[15]  J. Casanova,et al.  The 2017 IUIS Phenotypic Classification for Primary Immunodeficiencies , 2017, Journal of Clinical Immunology.

[16]  C. Klein,et al.  Targeted Gene Panel Sequencing for Early-onset Inflammatory Bowel Disease and Chronic Diarrhea , 2017, Inflammatory bowel diseases.

[17]  L. Notarangelo,et al.  Corrigendum: Natural Killer Cells from Patients with Recombinase-Activating Gene and Non-Homologous End Joining Gene Defects Comprise a Higher Frequency of CD56bright NKG2A+++ Cells, and Yet Display Increased Degranulation and Higher Perforin Content , 2017, Front. Immunol..

[18]  P. Hodgkin,et al.  Epistatic interactions between mutations of TACI (TNFRSF13B) and TCF3 result in a severe primary immunodeficiency disorder and systemic lupus erythematosus , 2017, Clinical & translational immunology.

[19]  M. Afarideh,et al.  Clinical, immunologic, and genetic spectrum of 696 patients with combined immunodeficiency , 2017, The Journal of allergy and clinical immunology.

[20]  Michael Seleman,et al.  Uses of Next-Generation Sequencing Technologies for the Diagnosis of Primary Immunodeficiencies , 2017, Front. Immunol..

[21]  L. Notarangelo,et al.  Natural Killer Cells from Patients with Recombinase-Activating Gene and Non-Homologous End Joining Gene Defects Comprise a Higher Frequency of CD56bright NKG2A+++ Cells, and Yet Display Increased Degranulation and Higher Perforin Content , 2017, Front. Immunol..

[22]  R. Ramirez-Solis,et al.  Combined immunodeficiency with severe inflammation and allergy caused by ARPC1B deficiency. , 2017, The Journal of allergy and clinical immunology.

[23]  N. Warner,et al.  Loss of the Arp2/3 complex component ARPC1B causes platelet abnormalities and predisposes to inflammatory disease , 2017, Nature Communications.

[24]  C. Cancrini,et al.  Late‐onset combined immune deficiency due to LIGIV mutations in a 12‐year‐old patient , 2017, Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology.

[25]  L. Notarangelo,et al.  Targeted strategies directed at the molecular defect: Toward precision medicine for select primary immunodeficiency disorders. , 2017, The Journal of allergy and clinical immunology.

[26]  O. Sanal,et al.  Investigation of Genetic Defects in Severe Combined Immunodeficiency Patients from Turkey by Targeted Sequencing , 2017, Scandinavian journal of immunology.

[27]  L. Notarangelo,et al.  Agammaglobulinemia associated to nasal polyposis due to a hypomorphic RAG1 mutation in a 12 years old boy. , 2016, Clinical Immunology.

[28]  Carol J. Saunders,et al.  Diagnostics of Primary Immunodeficiencies through Next-Generation Sequencing , 2016, Front. Immunol..

[29]  Xavier Bossuyt,et al.  Exome and genome sequencing for inborn errors of immunity. , 2016, The Journal of allergy and clinical immunology.

[30]  J. Lupski,et al.  Rapid molecular diagnostics of severe primary immunodeficiency determined by using targeted next-generation sequencing. , 2016, The Journal of allergy and clinical immunology.

[31]  J. Casanova,et al.  Genetic Diagnosis Using Whole Exome Sequencing in Common Variable Immunodeficiency , 2016, Front. Immunol..

[32]  A. Al-ghonaium,et al.  Unbiased targeted next-generation sequencing molecular approach for primary immunodeficiency diseases. , 2016, The Journal of allergy and clinical immunology.

[33]  B. Lambrecht,et al.  Genes associated with common variable immunodeficiency: one diagnosis to rule them all? , 2016, Journal of Medical Genetics.

[34]  M. Lenardo,et al.  Genomics of Immune Diseases and New Therapies. , 2016, Annual review of immunology.

[35]  L. Notarangelo,et al.  Human RAG mutations: biochemistry and clinical implications , 2016, Nature Reviews Immunology.

[36]  Jianguo Zhang,et al.  Next Generation Sequencing Data Analysis in Primary Immunodeficiency Disorders – Future Directions , 2016, Journal of Clinical Immunology.

[37]  C. Cancrini,et al.  Combined immunodeficiency due to JAK3 mutation in a child presenting with skin granuloma. , 2016, The Journal of allergy and clinical immunology.

[38]  K. M. McSweeney,et al.  Clinical application of whole-genome sequencing in patients with primary immunodeficiency. , 2015, The Journal of allergy and clinical immunology.

[39]  Smita Y. Patel,et al.  Application of whole genome and RNA sequencing to investigate the genomic landscape of common variable immunodeficiency disorders , 2015, Clinical immunology.

[40]  S. Spector,et al.  Practice parameter for the diagnosis and management of primary immunodeficiency. , 2015, The Journal of allergy and clinical immunology.

[41]  J. Casanova,et al.  Novel Primary Immunodeficiency Candidate Genes Predicted by the Human Gene Connectome , 2015, Front. Immunol..

[42]  O. Ohara,et al.  RAG1 Deficiency May Present Clinically as Selective IgA Deficiency , 2015, Journal of Clinical Immunology.

[43]  L. Moens,et al.  Diagnostics of Primary Immunodeficiency Diseases: A Sequencing Capture Approach , 2014, PloS one.

[44]  L. Notarangelo,et al.  A hypomorphic recombination-activating gene 1 (RAG1) mutation resulting in a phenotype resembling common variable immunodeficiency. , 2014, The Journal of allergy and clinical immunology.

[45]  Thomas A. Fleisher,et al.  Targeted NGS: A Cost-Effective Approach to Molecular Diagnosis of PIDs , 2014, Front. Immunol..

[46]  J. Casanova,et al.  Guidelines for genetic studies in single patients: lessons from primary immunodeficiencies , 2014, The Journal of experimental medicine.

[47]  A. Fischer,et al.  Contribution of high‐throughput DNA sequencing to the study of primary immunodeficiencies , 2014, European journal of immunology.

[48]  Toshiro K. Ohsumi,et al.  Lessons in gene hunting: a RAG1 mutation presenting with agammaglobulinemia and absence of B cells. , 2014, The Journal of allergy and clinical immunology.

[49]  S. Kingsmore,et al.  Utility of Next Generation Sequencing in Clinical Primary Immunodeficiencies , 2014, Current Allergy and Asthma Reports.

[50]  H. Ochs,et al.  Primary immunodeficiency disorders: general classification, new molecular insights, and practical approach to diagnosis and treatment. , 2014, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[51]  Jana Marie Schwarz,et al.  MutationTaster2: mutation prediction for the deep-sequencing age , 2014, Nature Methods.

[52]  Timur Zhiyentayev,et al.  Single-cell in situ RNA profiling by sequential hybridization , 2014, Nature Methods.

[53]  J. Shendure,et al.  A general framework for estimating the relative pathogenicity of human genetic variants , 2014, Nature Genetics.

[54]  E. Cuppen,et al.  Targeted next-generation sequencing: a novel diagnostic tool for primary immunodeficiencies. , 2014, The Journal of allergy and clinical immunology.

[55]  T. Jean,et al.  Variability In Measurement Of Allergen Skin Testing Results Among Allergy-Immunology Specialists , 2014 .

[56]  R. D'Souza,et al.  Functional evaluation of a novel tooth agenesis-associated bone morphogenetic protein 4 prodomain mutation. , 2013, European journal of oral sciences.

[57]  Heng Li.  Aligning sequence reads, clone sequences and assembly contigs with BWA-MEM , 2013, 1303.3997.

[58]  I. Adzhubei,et al.  Predicting Functional Effect of Human Missense Mutations Using PolyPhen‐2 , 2013, Current protocols in human genetics.

[59]  Gabor T. Marth,et al.  Haplotype-based variant detection from short-read sequencing , 2012, 1207.3907.

[60]  C. Murre,et al.  The function of E- and id proteins in lymphocyte development , 2001, Nature Reviews Immunology.

[61]  K. Weinberg,et al.  Novel splicing, missense, and deletion mutations in seven adenosine deaminase-deficient patients with late/delayed onset of combined immunodeficiency disease. Contribution of genotype to phenotype. , 1993, The Journal of clinical investigation.

[62]  M. Cooper,et al.  Primary immunodeficiencies. , 2003, American family physician.

[63]  Alexis B. Carter,et al.  Standards and Guidelines for Validating Next-Generation Sequencing Bioinformatics Pipelines: A Joint Recommendation of the Association for Molecular Pathology and the College of American Pathologists. , 2018, The Journal of molecular diagnostics : JMD.

[64]  Ivan K. Chinn,et al.  Primary immunodeficiency diseases: Genomic approaches delineate heterogeneous Mendelian disorders , 2017, The Journal of allergy and clinical immunology.

[65]  H. Kanegane,et al.  Targeted Sequencing and Immunological Analysis Reveal the Involvement of Primary Immunodeficiency Genes in Pediatric IBD: a Japanese Multicenter Study , 2016, Journal of Clinical Immunology.

[66]  L. Notarangelo,et al.  Primary immunodeficiencies. , 2010, The Journal of allergy and clinical immunology.

[67]  S. Henikoff,et al.  Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm , 2009, Nature Protocols.

[68]  Justin C. Fay,et al.  Identification of deleterious mutations within three human genomes. , 2009, Genome research.

[69]  E. Brooks,et al.  V(D)J recombination defects in lymphocytes due to RAG mutations: severe immunodeficiency with a spectrum of clinical presentations. , 2001, Blood.

[70]  Alexis B. Carter,et al.  SPECIAL ARTICLE Standards and Guidelines for Validating Next-Generation Sequencing Bioinformatics Pipelines A Joint Recommendation of the Association for Molecular Pathology and the College of American Pathologists , 2022 .